Unbalanced Collisions: NFL Concussion Protocols and Ongoing Compliance Challenges

The NFL season is back! Fans are buzzing about new uniforms, preseason rankings, and highlight-worthy plays, and there’s plenty to get excited about. Yet amid all the excitement, one issue continues to remain a pressing concern – the health and safety of the players. Football delivers thrills on the field, but the physical toll on athletes often lasts long after the final whistle. This season offers a chance to take a closer look at how far the NFL has come and how much work remains when it comes to protecting its players.

Large Law Firms v. Small: A Two-Tier Professional Responsibility System

The legal profession has long emphasized a standard of professional responsibility. These rules have been “uniformly” applied to all licensed attorneys in the country. In practice, however, the realities of firm size can create what appears to be a two-tier system of professional responsibility. Large law firms operate under intense regulatory, reputational, and insurance oversight, while small firms and solo practitioners are often equipped with fewer resources which can expose them to disciplinary scrutiny more easily. These dynamics shape the ethical landscape of the legal profession.

The Regulation of Cosmetics in the U.S.: Where It’s Been and Now Is Headed

The cosmetics industry in the U.S. has fallen behind in safety regulations compared to its European counterparts. The European Union has banned roughly 1,300 different ingredients in personal care products while the U.S. has banned merely 11. The last major update to regulations in the U.S. was in 2022 with the Modernization of Cosmetics Regulation Act (MoCRA). However, there is still work that needs to be done to address the health and safety risks that the cosmetic industry poses. The “Safer Beauty Bill Package” is just one proposed regulation that would majorly alter how personal care products are regulated in the U.S.

Continuity Across Administrations in Antitrust Law

In April 2025, the Federal Trade Commission (FTC) decided to pursue an antitrust trial against Meta. This conflict was initiated back in 2020 during the Trump administration, which continued throughout Biden’s time in office, and is now being brought to fruition. This case involves the alleged monopoly of social networking services as a result of Meta’s acquisition of Instagram and, more recently, WhatsApp. Regardless of the administration, antitrust agencies remain committed to challenging harmful business practices in the tech sector.

The IPO of Fannie Mae and Freddie Mac Could Provide Instability to an Already Weak U.S. Housing Market

Last month, the Trump Administration announced that it is pursuing an initial public offering (IPO) of the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac), both of which are currently under government conservatorship and overseen by the Federal Housing Finance Agency (FHFA). While there is no guarantee that the deal will move forward, President Donald Trump, FHFA Director Bill Plute, and Commerce Secretary Howard Lutnick believe the offering will take place soon, potentially later this year. While boasted as a great deal by the Trump Administration, given the size, risks, and the likely results that will follow the deals commencement, it is more likely to destabilize the mortgage market and further harm the currently sluggish U.S. housing market than to provide any benefit to U.S. citizens.

The Cost of Beauty: Chemical Compliance in Cosmetics

Have you ever considered the cost of beauty? The health cost, not the financial one, although both are considerably pricey. A bonded lash, a swipe of nail polish, a hair straightening treatment, and many other cosmetic and personal care products may contain harmful chemicals, including formaldehyde – a colorless carcinogen – or formaldehyde-releasers, like methylene glycol or dimethyl hydantoin (DMDM).

Navigating the Complex Landscape of Reproductive Healthcare Compliance

In the constantly evolving field of reproductive healthcare, compliance with regulatory standards is both challenging and vital. As legal frameworks shift and new technologies emerge, healthcare providers, law students, practitioners, and compliance professionals must stay informed to ensure adherence to the law. Several key compliance issues in reproductive healthcare, including privacy concerns raised by biometric technology as it is tied to employers, offer insights into the challenges and strategies for maintaining regulatory compliance.

Administrative Agencies and the Fight Over Regulatory Control

The regulatory state has expanded from the time of our founding. After the growth of industry and the expansion of interstate trade, the government understandably sought new ways to address increasingly complex problems. New agencies were created, such as the Environmental Protection Agency, the Food and Drug Administration, and the Federal Trade Commission (EPA, FDA , and FTC) who were charged with regulating different areas of commerce. This outgrowth was necessary to address changes in American markets. Over recent years, however, this expansion has become overly complex and has given too much authority to administrative agencies. In 2022 the state of West Virginia sought to rein in the regulatory powers of administrative agencies in the landmark Supreme Court case West Virginia v. EPA.  

Regulating Artificial Intelligence in the World of Insurance: Illinois’ Stalled Legislative Effort

The rapidly growing use of artificial intelligence (AI) has resulted in corporations having to find the balance between regulation and efficiency, and the world of insurance is no exception. As part of this transformation, insurance companies such as UnitedHealth Group and Humana have integrated AI into their claims evaluation system as a tool to process claims efficiently. UnitedHealth Group states that AI can better analyze data, process claims, detect fraud and provide more effective customer service. However, critics challenge this assessment, citing bias and privacy concerns. During the 2025 legislative session, Illinois pushed to regulate insurance agencies operating in the state through Illinois House Bill 0035. However, the legislation stalled in the Illinois Senate and did not advance during the 2025 legislative session.